Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Journal of Thoracic Disease|October 9, 2013
Therapeutic procedure in small cell lung cancerAnastasios Kallianos, Aggeliki Rapti, Paul Zarogoulidis, et al.Respiratory Medicine Case Reports|August 2, 2017
EGFR or PD-L1 decision for first line therapy in a case series of EGFR positive and PD-L1 >50Paul Zarogoulidis, Panos Chinelis, Christofors Efthymiou, et al.Patient Preference and Adherence|August 29, 2015
Reduction of exercise capacity in sarcoidosis in relation to disease severityAnastasios Kallianos, Paul Zarogoulidis, Fotini Ampatzoglou, et al.American Journal of Hypertension|March 5, 2011
Association of sarcoidosis with endothelial function, arterial wall properties, and biomarkers of inflammationGerasimos Siasos, Dimitris Tousoulis, Elias Gialafos, et al.Respiratory Medicine Case Reports|May 3, 2018
Convex-probe endobronchial ultrasound for thyroid biopsy a new hybrid methodKonstantinos Sapalidis, Christoforos Kosmidis, Stella Laskou, et al.Clinical Interventions in Aging|August 29, 2015
Sex differences of continuous positive airway pressure treatment on flow-mediated dilation in patients with obstructive sleep apnea syndromeAnastasios Kallianos, Athanasios Panoutsopoulos, Christoforos Mermigkis, et al.Sleep & Breathing = Schlaf & Atmung|March 17, 2010
How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis?Charalampos Mermigkis, Eleni Stagaki, Stavros Tryfon, et al.Frontiers in Medicine|December 1, 2022
Small airways dysfunction in patients with systemic sclerosis and interstitial lung diseasePanagiotis K Panagopoulos, Andreas V Goules, Vasiliki E Georgakopoulou, et al.Respiratory Medicine Case Reports|July 29, 2017
Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three casesPaul Zarogoulidis, Panos Chinelis, Anastasia Athanasiadou, et al.Respiratory Medicine Case Reports|November 11, 2017
Immunotherapy "Shock" with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinomaPaul Zarogoulidis, Haidong Huang, Theodora Tsiouda, et al.Pageof 5